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Juvenile systemic sclerosis (jSSc) is a rare autoimmune
disease in childhood. Currently data regarding long-term
outcome of jSSc is scare. We evaluated a large single centre
cohort to learn more about the characteristics of jSSc
patients in an adult cohort.
From more than 1800 cases of SSc, 46 adults with jSSc
were identified. The median age of onset was 13.06 years
(range 5 to 16). 35 (76%) were female. Median age at last
visit was 32.67 years (range 16 to 71). The median disease
duration was 21.15 years (range 3 to 58). 39% of the
patients had a diffuse and 61% a limited subtype of SSc.
20 (43.5%) of the 46 patients showed overlap features of
other connective tissue diseases. Three (6.5%) patients
had anticentromere antibodies. 12 (26%) patients were
anti-Scl 70 positive. The most common organ involve-
ments were oesophageal in 33 patients (72%), pulmonary
fibrosis in 22 patients (47%), bowel involvement in 9
patients (20%) and pulmonary hypertension in 7 patients
(15%). Interestingly 7 patients (15%) did not have any
major organ involvement beside skin and vascular
involvement. The survival of the 46 patients after 15, 20
and 25 years was 97%, 93% and 83%. The mean disease
duration of these patients was 28.86 years (range 17 to
47).
This patient population has similar organ involvement
and disease subtype characteristics as expected from an
adult SSc cohort. It is likely the study cohort of patients
reflect a survival bias. The antinuclear antibody pattern
contrasts markedly with adult SSc.
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